Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiology | 1 | 2022 | 34 | 0.710 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2022 | 75 | 0.690 |
Why?
|
| Ear Diseases | 1 | 2021 | 7 | 0.670 |
Why?
|
| Students, Medical | 1 | 2022 | 126 | 0.650 |
Why?
|
| Cervical Vertebrae | 1 | 2021 | 50 | 0.650 |
Why?
|
| Head | 1 | 2016 | 56 | 0.450 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2021 | 907 | 0.450 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2020 | 1224 | 0.430 |
Why?
|
| Body Composition | 1 | 2016 | 327 | 0.420 |
Why?
|
| Cocaine | 4 | 2008 | 354 | 0.350 |
Why?
|
| Silicone Oils | 2 | 2021 | 10 | 0.320 |
Why?
|
| Cocaine-Related Disorders | 2 | 2008 | 125 | 0.300 |
Why?
|
| Labyrinth Diseases | 2 | 2020 | 7 | 0.290 |
Why?
|
| Brain | 1 | 2016 | 965 | 0.290 |
Why?
|
| Reinforcement Schedule | 2 | 2008 | 103 | 0.270 |
Why?
|
| Dopamine | 2 | 2007 | 262 | 0.270 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2007 | 30 | 0.260 |
Why?
|
| Nucleus Accumbens | 2 | 2007 | 121 | 0.260 |
Why?
|
| Motivation | 1 | 2007 | 120 | 0.250 |
Why?
|
| Motor Activity | 1 | 2007 | 332 | 0.220 |
Why?
|
| Prevalence | 3 | 2021 | 955 | 0.200 |
Why?
|
| Young Adult | 3 | 2021 | 2649 | 0.200 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 3900 | 0.190 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2022 | 14 | 0.190 |
Why?
|
| Anesthesia, Epidural | 1 | 2022 | 21 | 0.190 |
Why?
|
| Cranial Nerves | 1 | 2022 | 7 | 0.190 |
Why?
|
| Analgesia, Epidural | 1 | 2022 | 48 | 0.180 |
Why?
|
| Male | 11 | 2021 | 19441 | 0.180 |
Why?
|
| Educational Measurement | 1 | 2022 | 113 | 0.170 |
Why?
|
| Humans | 11 | 2022 | 32282 | 0.170 |
Why?
|
| Vitreous Body | 1 | 2021 | 10 | 0.170 |
Why?
|
| Infant | 2 | 2021 | 1010 | 0.170 |
Why?
|
| Cerebral Hemorrhage, Traumatic | 1 | 2020 | 2 | 0.160 |
Why?
|
| Diverticulum | 1 | 2020 | 11 | 0.160 |
Why?
|
| Hearing Loss | 1 | 2020 | 25 | 0.160 |
Why?
|
| Child, Preschool | 2 | 2021 | 1233 | 0.160 |
Why?
|
| Retrospective Studies | 4 | 2021 | 3626 | 0.160 |
Why?
|
| Football | 1 | 2020 | 67 | 0.150 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2018 | 5 | 0.140 |
Why?
|
| Practice Management, Medical | 1 | 2018 | 7 | 0.140 |
Why?
|
| Adolescent | 3 | 2021 | 3519 | 0.140 |
Why?
|
| Infant, Newborn | 1 | 2021 | 666 | 0.140 |
Why?
|
| Middle Aged | 4 | 2021 | 11851 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 757 | 0.140 |
Why?
|
| Adult | 3 | 2021 | 9259 | 0.130 |
Why?
|
| Substance Withdrawal Syndrome | 3 | 2007 | 76 | 0.130 |
Why?
|
| Child | 2 | 2021 | 2435 | 0.130 |
Why?
|
| Aged | 3 | 2021 | 10263 | 0.130 |
Why?
|
| Cerebellopontine Angle | 1 | 2017 | 3 | 0.130 |
Why?
|
| Cerebellar Diseases | 1 | 2017 | 4 | 0.130 |
Why?
|
| Ear, Inner | 1 | 2017 | 8 | 0.130 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2017 | 17 | 0.130 |
Why?
|
| Female | 6 | 2021 | 19945 | 0.120 |
Why?
|
| Radiography, Abdominal | 1 | 2016 | 15 | 0.120 |
Why?
|
| Abdominal Fat | 1 | 2016 | 39 | 0.120 |
Why?
|
| Self Administration | 4 | 2008 | 382 | 0.100 |
Why?
|
| Adipose Tissue | 1 | 2016 | 320 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2008 | 897 | 0.090 |
Why?
|
| Rats | 4 | 2008 | 1895 | 0.080 |
Why?
|
| Microdialysis | 2 | 2007 | 41 | 0.080 |
Why?
|
| Dextroamphetamine | 1 | 2008 | 17 | 0.070 |
Why?
|
| Central Nervous System Stimulants | 1 | 2008 | 82 | 0.070 |
Why?
|
| Narcotics | 1 | 2006 | 32 | 0.060 |
Why?
|
| Heroin | 1 | 2006 | 33 | 0.060 |
Why?
|
| Presynaptic Terminals | 1 | 2005 | 39 | 0.060 |
Why?
|
| Animals | 5 | 2008 | 8199 | 0.050 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2005 | 147 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2004 | 106 | 0.050 |
Why?
|
| Epidural Space | 1 | 2022 | 8 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 245 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2008 | 717 | 0.040 |
Why?
|
| Retinal Detachment | 1 | 2020 | 10 | 0.040 |
Why?
|
| Athletes | 1 | 2020 | 62 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2020 | 95 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2020 | 103 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2004 | 595 | 0.040 |
Why?
|
| Workflow | 1 | 2018 | 20 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 38 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 504 | 0.040 |
Why?
|
| Software | 1 | 2018 | 124 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 762 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1241 | 0.030 |
Why?
|
| Decision Making | 1 | 2018 | 189 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2008 | 276 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2018 | 330 | 0.030 |
Why?
|
| Behavior, Animal | 2 | 2008 | 299 | 0.030 |
Why?
|
| Quinpirole | 1 | 2005 | 16 | 0.010 |
Why?
|
| Extracellular Space | 1 | 2005 | 28 | 0.010 |
Why?
|
| Dopamine Agonists | 1 | 2005 | 30 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2005 | 86 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2005 | 46 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2004 | 9 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 52 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 64 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2004 | 131 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 184 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 729 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 2205 | 0.010 |
Why?
|
| Mice | 1 | 2004 | 2571 | 0.010 |
Why?
|